Literature DB >> 11070452

Effects of hemoglobin on pulmonary arterial pressure and pulmonary vascular resistance in patients with chronic emphysema.

A Nakamura1, N Kasamatsu, I Hashizume, T Shirai, S Hanzawa, S Momiki, K Sasaki, M Kinoshita, O Okada, K Tatsumi, T Kuriyama.   

Abstract

BACKGROUND: The increase in viscosity caused by secondary polycythemia is thought to be one of the major causes of pulmonary hypertension secondary to chronic emphysema. However, very few clinical studies considered the relation between pulmonary hypertension and polycythemia in the case of chronic obstructive pulmonary disease.
OBJECTIVE: The purpose of this study is to elucidate the relative contribution of an increase in hemoglobin level (Hb) to mean pulmonary arterial pressure (mPAP) and pulmonary vascular resistance (PVR).
METHODS: We retrospectively investigated 41 patients with chronic emphysema who had undergone a right heart catheterization. Multiple-regression analysis and F test were performed to investigate both direct effects of Hb and PaO(2) as independent variables on mPAP and PVR as dependent variables.
RESULTS: Significant correlations were found between PaO(2) and mPAP (or PVR), or Hb and mPAP (or PVR), indicating that both Hb and PaO(2) are contributory to mPAP and PVR. The F test demonstrated that Hb and PaO(2) could directly affect the level of either mPAP or PVR.
CONCLUSIONS: It was concluded that Hb had a direct effect on mPAP and PVR, independently of hypoxia in patients with chronic emphysema. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11070452     DOI: 10.1159/000067463

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  12 in total

1.  Oxygen Desaturation in Daily Life and During a Laboratory-Based Protocol of Activities of Daily Living in COPD: Is There Relationship?

Authors:  Thaís Sant'Anna; Leila Donária; Nidia A Hernandes; Karina C Furlanetto; Décio S Barbosa; Rik Gosselink; Fabio Pitta
Journal:  Lung       Date:  2017-11-13       Impact factor: 2.584

2.  Relationship between polycythemia and in-hospital mortality in chronic obstructive pulmonary disease patients with low-risk pulmonary embolism.

Authors:  Lu Guo; Aamer Rasheed Chughtai; Hongli Jiang; Lingyun Gao; Yan Yang; Yang Yang; Yuejian Liu; Zhenliang Xie; Weimin Li
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

3.  Pulmonary artery pressure and iron deficiency in patients with upregulation of hypoxia sensing due to homozygous VHL(R200W) mutation (Chuvash polycythemia).

Authors:  Craig A Sable; Zakari Y Aliyu; Niti Dham; Mehdi Nouraie; Vandana Sachdev; Stanislav Sidenko; Galina Y Miasnikova; Lydia A Polyakova; Adelina I Sergueeva; Daniel J Okhotin; Vladimir Bushuev; Alan T Remaley; Xiaomei Niu; Oswaldo L Castro; Mark T Gladwin; Gregory J Kato; Josef T Prchal; Victor R Gordeuk
Journal:  Haematologica       Date:  2011-10-11       Impact factor: 9.941

Review 4.  State of the Art Review of the Right Ventricle in COPD Patients: It is Time to Look Closer.

Authors:  Daniela Graner Schuwartz Tannus-Silva; Marcelo Fouad Rabahi
Journal:  Lung       Date:  2016-12-03       Impact factor: 2.584

5.  JNK2 up-regulates hypoxia-inducible factors and contributes to hypoxia-induced erythropoiesis and pulmonary hypertension.

Authors:  Marc A Sala; Cong Chen; Qiao Zhang; Hanh Chi Do-Umehara; Wenjiao Wu; Alexander V Misharin; Gregory B Waypa; Deyu Fang; G R Scott Budinger; Shuwen Liu; Navdeep S Chandel; Paul T Schumacker; Jacob I Sznajder; Jing Liu
Journal:  J Biol Chem       Date:  2017-11-08       Impact factor: 5.157

6.  Pulmonary Hypertension Secondary to COPD.

Authors:  Adil Shujaat; Abubakr A Bajwa; James D Cury
Journal:  Pulm Med       Date:  2012-08-29

Review 7.  Hypoxemia in patients with COPD: cause, effects, and disease progression.

Authors:  Brian D Kent; Patrick D Mitchell; Walter T McNicholas
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2011-03-14

8.  Secondary polycythemia in chronic obstructive pulmonary disease: prevalence and risk factors.

Authors:  Michael H Cho; Brian D Hobbs; Jingzhou Zhang; Dawn L DeMeo; Edwin K Silverman; Barry J Make; R Chad Wade; J Michael Wells
Journal:  BMC Pulm Med       Date:  2021-07-14       Impact factor: 3.320

Review 9.  Pulmonary hypertension associated with COPD.

Authors:  Jean Elwing; Ralph J Panos
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

10.  Associations between diabetes mellitus and pulmonary hypertension in chronic respiratory disease patients.

Authors:  Tomoko Takahashi; Akiomi Yoshihisa; Koichi Sugimoto; Tetsuro Yokokawa; Tomofumi Misaka; Takashi Kaneshiro; Masayoshi Oikawa; Atsushi Kobayashi; Kazuhiko Nakazato; Takafumi Ishida; Yasuchika Takeishi
Journal:  PLoS One       Date:  2018-10-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.